Last reviewed · How we verify
NCT07036081: Wilbo's Blends
A Single Arm Intervention Study to Assess the Acceptability, Tolerance and Ease of Use of Wilbo's Blends+ (Commercial Enteral Feed Based on Real Food) When Used as Part of a Dietitian Prescribed Enteral Feeding Plan
NA trial testing Wilbo's Blends+ in Enteral Nutrition (Food for Special Medical Purposes) in 45 participants. Completed in 31 March 2026.
31 March 2026
Quick facts
| Lead sponsor | Nottingham University Hospitals NHS Trust |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 45 |
| Start date | 16 October 2025 |
| Primary completion | 31 March 2026 |
| Estimated completion | 31 March 2026 |
| Sites | 1 location across United Kingdom |
Drugs / interventions tested
- Wilbo's Blends+
Conditions studied
- Enteral Nutrition (Food for Special Medical Purposes) — all drugs for Enteral Nutrition (Food for Special Medical Purposes) →
- Enteral Feeds — all drugs for Enteral Feeds →
- Enteral Tube Nutrition — all drugs for Enteral Tube Nutrition →
- Gastrostomy Tube — all drugs for Gastrostomy Tube →
Sponsor
Nottingham University Hospitals NHS Trust
Who can join
Adults 3 to 15, any sex, with Enteral Nutrition (Food for Special Medical Purposes) or Enteral Feeds. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this observational study is to learn if tube-fed children and young people (age 3-15 years) find Wilbo's Blends+ (a new nutritionally complete enteral formula containing real food ingredients) acceptable, tolerable and easy to use. The main question it aims to answer is: Is Wilbo's Blends+ acceptable when included in the feeding plan of tube-fed children and young people (age 3-15 years) Participants will: Take Wilbo's Blend+ for a 7 day period as part of their feeding plan Complete questionnaires about their gastrointestinal symptoms
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT07036081
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Nottingham University Hospitals NHS Trust trials
Trials by the same sponsor.
- NCT07350408 — Mapping Post-falls Organisational Processes in Care Homes · recruiting
- NCT07303569 — Prevention of Pressure Injury (PI) in Hospitalised Infants, Children, and Young People (CYP) (Aged 0-19 Years) · recruiting
- NCT06572345 — Low EnerGy DiEt iN Adolescents With Obesity and Type 2 Diabetes: The LEGEND Study · NA · recruiting
- NCT07136298 — Seizure Identification on the Intensive Care Unit (ICU) · recruiting
- NCT06585293 — Comparability of Fingerprick vs Venous Blood for Tacrolimus Monitoring · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07036081 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Nottingham University Hospitals NHS Trust
- Last refreshed: 1 April 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07036081.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing